NYSE
CLX
Last Price
US $105.70
KEY FIGURES
MKT CAP
$12.8B
EPS
TTM
$4.82
PEG
TTM
N/M
P/E
TTM
21.93x
P/S
TTM
1.92x
YIELD
4.70%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
249.61%
Return on equity
ROIC: 25.82%
Valuation History
18.4X
Price to Earnings
EV/EBITDA: 12.7X
Cash flow
Profit margin
-1.75%
(FY vs FY)
EBITDA Y/Y
-5.31%
(FY vs FY)
Cash flow Y/Y
-10.05%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $105.70
-76.72%
Default assumptions
EBITDA Multiple
Fair Value
Market $105.70
-45.14%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
The Clorox Company cash flow to debt ratio of 17.77% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
The Clorox Company's free cash flow has increased 57.56% from $483.00M last year to $761.00M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
The Clorox Company's debt to equity ratio is 61.33, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
The Clorox Company's debt has increased relative to shareholder equity from 8.97 last year to 61.33 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
The Clorox Company has a net debt to EBITDA ratio of 5.84x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
The Clorox Company's interest coverage ratio of 12.78 indicates that earnings with good margin can cover interest payments on company debt
Financial risk - Profit margin growth.
The Clorox Company's profit margin has decreased (-23.39%) in the last year from 11.40% to 8.74%, signaling decreasing performance
Financial risk - Short term assets vs short term liabilities.
The Clorox Company's short-term liabilities of $2.77G exceed its short-term assets of $1.82G, signaling financial risk
Increasing performance - ROA.
The Clorox Company's return on assets of 7.53% is higher than the 5.00% threshold, indicating efficient asset utilization
Decreasing performance - Absolute return on equity.
The Clorox Company's return on equity of -1.89K%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
The Clorox Company's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
The Clorox Company had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
The Clorox Company has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
The Clorox Company has a free cash flow yield of 5.95%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Decreasing performance - Healthy earnings growth.
The Clorox Company's yearly earnings has decreased -27.53% since last year from $810.00M to $587.00M, signaling decreasing performance
Decreasing performance - Healthy revenue growth.
The Clorox Company's yearly revenue has decreased -5.41% since last year from $7.10G to $6.72G, signaling decreasing performance
Increasing performance - ROIC.
ROIC 20.39% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Decreasing performance - 3-year revenue CAGR.
The Clorox Company's 3-year revenue CAGR of -3.11% is negative, indicating declining revenue over the past 3 years
Decreasing performance - Revenue consistency.
The Clorox Company had revenue growth in only 2.00 out of 5 years, indicating inconsistent revenue performance
Increasing performance - ROE consistency.
The Clorox Company had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
The Clorox Company is overvalued relative to its fair value price of 24.61 based on Discounted Cash Flow model
Undervalued - Earnings yield.
The Clorox Company has an earnings yield of 4.56%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
The Clorox Company is overvalued relative to its fair value price of 57.99 based on EBITDA multiple model
Undervalued - EV/EBITDA.
The Clorox Company has an EV/EBITDA ratio of 19.72x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
The Clorox Company has no meaningful EPS growth rate; PEG ratio cannot be computed.
Overvalued - P/B ratio.
The Clorox Company has a price-to-book ratio of 51.08x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value
Undervalued - P/S ratio.
The Clorox Company has a price-to-sales ratio of 1.92x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue